On this page
Chromosome 2
Second-largest chromosome - a fusion of two ancestral primate chromosomes, unique to humans.
Schematic of chromosome 2 showing the short (p) and long (q) arms. Arm ratio per GRCh38 - banding schematic.
Available at Jeen Health
Clinical tests that include this
Overview
Chromosome 2 spans approximately 242.2 million base pairs and contains around 1,300 protein-coding genes, making it the second-largest of the 23 human chromosome pairs. It accounts for roughly 8% of the total DNA in each cell. This chromosome is classified as submetacentric, meaning its centromere sits somewhat off-centre, creating a moderately short p (petit, or short) arm and a longer q arm. Unlike the smaller acrocentric chromosomes (13, 14, 15, 21, 22), chromosome 2 does not carry ribosomal-RNA genes on its short arm.
Chromosome 2 holds a unique place in human evolutionary history: it represents the fusion of two medium-sized chromosomes that remain separate in other great apes such as chimpanzees, gorillas, and orangutans. Evidence of this ancient fusion event, occurring approximately 5-7 million years ago around the time of the human-chimpanzee divergence, can still be detected at the molecular level in band 2q14.3, where the remnants of two ancestral centromeres and telomeric sequences lie buried within the chromosome's internal structure. This evolutionary restructuring has no known effect on human health, but it serves as a molecular signature distinguishing humans from our closest primate relatives.
Clinically, chromosome 2 is best known for housing genes involved in DNA mismatch repair, connective-tissue synthesis, immune regulation, and muscle structure. Pathogenic variants in chromosome-2 genes underpin a spectrum of inherited conditions, from cancer-predisposition syndromes such as Lynch syndrome to connective-tissue disorders including vascular Ehlers-Danlos syndrome and developmental syndromes such as Mowat-Wilson syndrome.
Structure
Like all human chromosomes, chromosome 2 comprises a single continuous double helix of DNA wound around histone protein complexes to form nucleosomes. These nucleosomes coil and condense through successive levels of chromatin packaging, ultimately producing the characteristic X-shaped structure visible under a light microscope during cell division. The centromere, located somewhat off-centre, divides the chromosome into a short p arm and a long q arm. At the molecular level, the centromere consists of highly repetitive DNA sequences and specialised chromatin that anchor the protein machinery responsible for segregating chromosomes into daughter cells during mitosis and meiosis.
The fusion site at 2q14.3 represents a vestige of the event that joined two ancestral primate chromosomes. Molecular analysis reveals inverted telomeric repeats and the remnants of a second, now-inactive centromere at this internal location. This structural quirk has no impact on chromosome function or stability in modern humans but provides compelling evidence of our shared ancestry with other great apes. Each end of chromosome 2 is capped by a functional telomere, a protective sequence of repeated DNA that prevents the chromosome from being mistaken for a broken DNA strand and helps regulate the number of times a cell can divide.
Video: What is a karyotype?
Notable regions
The region at 2p16.3 contains the DNA mismatch-repair genes MSH2 and MSH6, which encode proteins that detect and correct errors introduced during DNA replication. These genes work as part of a surveillance system that scans newly copied DNA for mismatched base pairs and small insertion-deletion loops, recruiting other repair proteins to excise and re-synthesise the incorrect strand. Inherited pathogenic variants in MSH2 or MSH6 cause Lynch syndrome, an autosomal-dominant cancer-predisposition condition characterised by markedly increased risks of colorectal, endometrial, ovarian, gastric, and other cancers, often presenting before age 50. Within the NHS, individuals with a strong family history of these cancers may be referred for genetic testing, and those found to carry pathogenic variants are offered enhanced surveillance through colonoscopy and gynaecological screening.
Band 2q11.2 encompasses several genes, including TMEM127, associated with familial phaeochromocytoma, and is also the site of a recurrent microdeletion syndrome. Individuals with 2q11.2 deletions may present with developmental delay, intellectual disability, and variable dysmorphic features. The region also includes the centromeric end of the long arm, where structural rearrangements occasionally arise. Such copy-number variants are typically identified through chromosomal microarray analysis when a child is referred for investigation of unexplained developmental concerns.
The 2q22.3 band is home to ZEB2, a gene encoding a zinc-finger transcription factor essential for early embryonic development, particularly neural-crest migration and brain patterning. Pathogenic variants in ZEB2, or deletions encompassing the gene, cause Mowat-Wilson syndrome, a recognisable developmental disorder characterised by moderate to severe intellectual disability, distinctive facial features, epilepsy, and congenital anomalies including Hirschsprung disease and cardiac defects. Diagnosis is usually suspected on clinical grounds and confirmed by genomic testing.
At 2q32.2 sits COL3A1, which encodes the alpha-1 chain of type III collagen, a crucial structural protein in blood vessels, skin, and internal organs. Pathogenic variants in COL3A1 cause vascular Ehlers-Danlos syndrome, a life-threatening connective-tissue disorder marked by arterial, intestinal, and uterine fragility. Because of the high risk of spontaneous vascular rupture, individuals with vEDS require specialist multidisciplinary management, and genetic counselling is critical for at-risk relatives. The 2q33.1 region contains CTLA4, which encodes an immune-checkpoint protein that downregulates T-cell activation. Variants in CTLA4 have been associated with autoimmune conditions and immune dysregulation, underscoring the chromosome's role in both structural integrity and immune homeostasis.
Notable genes
MSH2 and MSH6 are among the most clinically significant genes on chromosome 2. Both encode components of the mismatch-repair machinery that maintains genomic stability. Pathogenic variants in either gene substantially increase lifetime cancer risk, particularly for colorectal and endometrial malignancies. Biallelic pathogenic variants in MSH2 or MSH6 cause constitutional mismatch-repair deficiency, a rare childhood-onset cancer syndrome with a markedly elevated risk of brain tumours, haematological malignancies, and gastrointestinal cancers, often presenting in the first or second decade of life.
The TTN gene at 2q31.2 is the largest known human gene, spanning approximately 280 kilobases (kb) of genomic DNA and encoding titin, a giant protein that functions as a molecular spring in cardiac and skeletal muscle sarcomeres. Truncating variants in TTN are a common cause of dilated cardiomyopathy, a condition in which the heart's left ventricle enlarges and weakens, impairing its ability to pump blood efficiently. COL3A1 and the related collagen genes on chromosome 2 contribute to the structural scaffold of connective tissues. APOB at 2p24.1 encodes apolipoprotein B, essential for the assembly and transport of lipoproteins; pathogenic variants can cause familial defective apolipoprotein B-100 (a form of familial hypercholesterolaemia) or familial hypobetalipoproteinaemia (associated with fat malabsorption and liver disease). PAX3 is a transcription factor critical for neural-crest and muscle development, and variants are linked to Waardenburg syndrome. ALK encodes a receptor tyrosine kinase implicated in certain paediatric and adult cancers when rearranged or mutated.
Chromosomal disorders
Chromosome 2 does not have a well-recognised whole-chromosome aneuploidy syndrome such as trisomy 21 or monosomy X. Complete trisomy 2 (three copies of the entire chromosome) and complete monosomy 2 (loss of one copy) are incompatible with survival beyond early embryonic development and can be detected as causes of miscarriage when karyotyping is performed on products of conception. For this reason, chromosome 2 is not among the aneuploidies routinely screened for by non-invasive prenatal testing.
However, partial duplications and deletions of chromosome 2 do occur and can result in recognisable clinical syndromes depending on the size and location of the imbalance. The 2q11.2 microdeletion syndrome, mentioned earlier, arises from the loss of a small segment encompassing several genes in the proximal long arm. Affected individuals may have developmental delay, learning difficulties, and minor facial differences. The phenotype is variable, and some individuals are only mildly affected, making genetic testing important for accurate diagnosis and family counselling.
Other structural rearrangements, such as translocations involving chromosome 2, are occasionally identified during karyotyping performed for recurrent miscarriage, infertility, or a family history of congenital anomalies. Balanced rearrangements (in which no genetic material is lost or gained) are usually clinically silent in the carrier but can lead to unbalanced offspring, prompting referral to clinical genetics services within the NHS for detailed risk assessment and reproductive counselling. De-novo copy-number variants on chromosome 2 may also be detected incidentally on chromosomal microarray when investigating developmental delay or multiple congenital anomalies, and interpretation requires comparison with population databases and, where possible, parental testing to determine whether the variant is inherited or arisen anew.
Prenatal screening & diagnosis
Because whole-chromosome trisomy or monosomy of chromosome 2 is lethal in early pregnancy, this chromosome is not included in the panel of aneuploidies assessed by standard non-invasive prenatal testing, which focuses on trisomies 13, 18, and 21, and the sex-chromosome aneuploidies. Ultrasound findings such as increased nuchal translucency, structural anomalies, or growth restriction during routine antenatal care may prompt further investigation, but these are non-specific and can arise from a wide range of genetic and non-genetic causes.
When a structural abnormality is detected on antenatal ultrasound, invasive testing such as amniocentesis or chorionic-villus sampling may be offered through NHS Fetal Medicine services to obtain foetal cells for karyotyping or chromosomal microarray analysis. These tests can identify partial duplications or deletions of chromosome 2, including microdeletion syndromes such as 2q11.2 deletion or pathogenic copy-number variants involving known disease genes. If a parent is known to carry a balanced translocation involving chromosome 2, preconception or prenatal genetic counselling through NHS clinical genetics services can help clarify recurrence risks and discuss reproductive options, including preimplantation genetic testing.
Postnatally, chromosomal microarray is the first-line test for children with unexplained developmental delay, autism spectrum disorder, or multiple congenital anomalies, and it can detect submicroscopic imbalances on chromosome 2 that would not be visible on a standard karyotype. Trio exome or genome sequencing is increasingly used to identify pathogenic sequence variants in chromosome-2 genes such as ZEB2, COL3A1, or MSH2 when the clinical presentation points towards a specific genetic syndrome.
Inheritance & recurrence
Most chromosomal abnormalities involving chromosome 2, such as de-novo microdeletions or duplications, arise sporadically and are not inherited from either parent. In such cases, the recurrence risk for future pregnancies is generally low, though not zero, because of the theoretical possibility of germline mosaicism (in which a proportion of a parent's egg or sperm cells carry the same rearrangement). By contrast, if a parent carries a balanced translocation involving chromosome 2, the risk of having a child with an unbalanced karyotype can be substantially higher, depending on the specific breakpoints and the segregation pattern during meiosis. Detailed risk estimation requires specialist input from a clinical geneticist or genetic counsellor.
For single-gene disorders caused by pathogenic variants in chromosome-2 genes, the inheritance pattern depends on the gene in question. Lynch syndrome, caused by variants in MSH2 or MSH6, follows autosomal-dominant inheritance: each child of an affected parent has a 50% chance of inheriting the variant. Vascular Ehlers-Danlos syndrome (COL3A1) is also autosomal dominant, though roughly half of cases arise from de-novo variants. Constitutional mismatch-repair deficiency and Perlman syndrome are autosomal recessive, requiring biallelic pathogenic variants, and carrier parents have a 25% recurrence risk in each pregnancy. Referral to an NHS clinical genetics service is recommended for families affected by these conditions to ensure accurate risk assessment, appropriate surveillance, and discussion of reproductive options such as preimplantation genetic testing or prenatal diagnosis.
Frequently asked questions
Why is chromosome 2 unique to humans?
Chromosome 2 formed when two medium-sized chromosomes that remain separate in other great apes fused together in an early human ancestor, approximately 5-7 million years ago around the time of the human-chimpanzee divergence. The fusion site, visible at band 2q14.3, contains remnants of telomeric sequences and a vestigial centromere. This event reduced the chromosome count in humans to 46, compared with 48 in chimpanzees, gorillas, and orangutans, but has no known effect on health or development.
What is Lynch syndrome, and how is it related to chromosome 2?
Lynch syndrome is an inherited cancer-predisposition condition caused by pathogenic variants in DNA mismatch-repair genes, including MSH2 and MSH6 on chromosome 2. People with Lynch syndrome have substantially increased risks of colorectal, endometrial, ovarian, and other cancers, often developing before age 50. Enhanced surveillance through regular colonoscopy and gynaecological screening is recommended, and genetic testing can identify at-risk family members who would benefit from the same preventive care.
Can abnormalities of chromosome 2 be detected before birth?
Whole-chromosome trisomy or monosomy of chromosome 2 is not compatible with life and is not screened for by routine non-invasive prenatal testing. However, partial duplications or deletions can be identified if invasive testing (amniocentesis or chorionic-villus sampling) is performed, typically because of ultrasound findings or a known parental chromosome rearrangement. Chromosomal microarray can detect submicroscopic imbalances involving chromosome 2, and the results inform genetic counselling and care planning.
What is vascular Ehlers-Danlos syndrome, and why is it serious?
Vascular Ehlers-Danlos syndrome is caused by pathogenic variants in the COL3A1 gene on chromosome 2, which encodes a major structural protein in blood-vessel walls, the intestines, and the uterus. People with vEDS are at risk of spontaneous arterial, bowel, or uterine rupture, often without warning, making it one of the most severe forms of Ehlers-Danlos syndrome. Specialist multidisciplinary care, avoidance of contact sports and heavy lifting, and genetic counselling for at-risk relatives are essential components of management.
If I carry a balanced translocation involving chromosome 2, what does that mean for my children?
A balanced translocation means you carry a rearrangement of genetic material between chromosome 2 and another chromosome, but no material is lost or gained, so you are typically healthy. However, during egg or sperm formation, the rearrangement can lead to unbalanced combinations in offspring, potentially causing miscarriage, developmental delay, or congenital anomalies. The specific risk depends on the chromosomes and breakpoints involved. NHS clinical genetics services can provide detailed counselling, discuss reproductive options, and offer prenatal or preimplantation genetic testing if desired.
Launch-set genes on chromosome 2
Genes on this chromosome that currently have dedicated pages in the library. This list grows as we publish more.